Resolvin E1, but not resolvins E2 and E3, promotes fMLF‐induced ROS generation in human neutrophils

E‐series resolvins are biosynthesized from eicosapentaenoic acid during the resolution phase of acute inflammation and enhance inflammation resolution. However, the role of E‐series resolvins in inflammation resolution is not yet known. Herein, we show that in human polymorphonuclear neutrophils (PM...

Full description

Saved in:
Bibliographic Details
Published in:FEBS letters 2018-08, Vol.592 (16), p.2706-2715
Main Authors: Unno, Yuka, Sato, Yoshinori, Fukuda, Hayato, Ishimura, Kohei, Ikeda, Hiroyuki, Watanabe, Mizuki, Tansho‐Nagakawa, Shigeru, Ubagai, Tsuneyuki, Shuto, Satoshi, Ono, Yasuo
Format: Article
Language:English
Subjects:
neutrophil
N‐formylmethionyl‐leucyl‐phenylalanine
reactive oxygen species
Resolvin E1
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:E‐series resolvins are biosynthesized from eicosapentaenoic acid during the resolution phase of acute inflammation and enhance inflammation resolution. However, the role of E‐series resolvins in inflammation resolution is not yet known. Herein, we show that in human polymorphonuclear neutrophils (PMNs), resolvin E1 (RvE1) selectively enhances reactive oxygen species (ROS) generation induced by N‐formylmethionyl‐leucyl‐phenylalanine. The RvE1‐mediated enhancement is eliminated by a pan‐antagonist of leukotriene B4 (LTB4) receptors, LY255283, or an NADPH oxidase inhibitor, diphenyleneiodonium. Thus, RvE1 enhances NADPH oxidase‐mediated ROS generation via LTB4 receptors. Unlike RvE1, resolvins E2 and E3 do not show such activation of PMNs. Our findings suggest that RvE1 contributes to regulation of ROS generation, in accordance with the inflammatory state of the host.
ISSN:0014-5793
1873-3468
DOI:10.1002/1873-3468.13215